$ABBV Recent Headlines Tesla cleared in German

New Post Public Reply Private Reply Replies (0) Message Board

Dec 3, 2013 at 3:34 PM

$ABBV Recent Headlines

Tesla cleared in German probe; Apple up on UBS upgrade
13 min ago3:20 p.m. Dec. 3, 2013
- Sue Chang

FDA approving drugs faster, and it may stay that way, report says

6:10 p.m. Nov. 18, 2013
- Russ Britt

AbbVie shares up on Hepatitis C results, but gains may be muted

11:49 a.m. Nov. 18, 2013
- Russ Britt

Mixed bag of earnings ends up badly for two health-care firms

10:22 a.m. Oct. 25, 2013
- Russ Britt

Microsoft, Amazon, Zynga are stocks to watch
4:31 a.m. Oct. 25, 2013
- Sue Chang

FDA recommends new limits on pain drugs
10:25 p.m. Oct. 24, 2013
- Thomas M. Burton

Abbott Labs sets a brisk earnings pace by beating income forecasts

10:43 a.m. Oct. 16, 2013
- Russ Britt

AbbVie net falls 16% on separation costs
8:58 a.m. July 26, 2013
- MarketWatch.com

4 things traders should know for the next 24 hours

4:46 p.m. July 25, 2013
- blogs.marketwatch.com

The Next 24: Starbucks Surges
4:13 p.m. July 25, 2013
- MarketWatch

Pharmacyclics seeks fast-track drug approval, makes double-digit gain

10:09 a.m. July 10, 2013
- Russ Britt

European regulators set precedent with approval of new copycat drugs

2:04 p.m. June 28, 2013
- Russ Britt

No rest for the weary, or even the savvy, in Wall Street carnage

4:21 p.m. June 20, 2013
- Russ Britt

Supreme Court satisfies few with ruling on generic drug settlements

4:30 p.m. June 18, 2013
- Russ Britt

Dan Loeb's cheap stock picks
11:39 a.m. June 18, 2013
- Insider Monkey

Pacts that delay sale of generics in jeopardy
1:55 a.m. June 18, 2013
- Brent Kendall

Supreme Court decision on generics hits Actavis, but few other drug firms

11:46 a.m. June 17, 2013
- Russ Britt

Abbott unveils $3 billion share-buyback program
2:22 p.m. June 14, 2013
- MarketWatch.com

Quant King Renaissance Technologies' stock picks
1:37 p.m. June 7, 2013
- Insider Monkey

Insiders and Dan Loeb like these stocks
11:00 a.m. June 4, 2013
- Insider Monkey

Pfizer out, AbbVie in on Goldman's CL-Buy list

8:45 a.m. Today8:45 a.m. Dec. 3, 2013
- Seeking Alpha

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More
8:29 a.m. Today8:29 a.m. Dec. 3, 2013
- 247WallSt.com

Investors Expect too Much of Salix

6:00 a.m. Dec. 2, 2013
- TheStreet.com

SDY Can Still Make You Money

4:21 p.m. Nov. 30, 2013
- Seeking Alpha

Health Canada Approves HUMIRA® (adalimumab) for the Treatment of Ulcerative Colitis (UC)
7:55 a.m. Nov. 28, 2013
- CNW Group

J&J's Olysio Approved in the U.S. - Analyst Blog

7:01 p.m. Nov. 26, 2013
- Zacks.com

A Look At Abbott's Vascular Division

3:29 p.m. Nov. 25, 2013
- Seeking Alpha

Achillion Pharmaceuticals: 3 Different Insiders Have Purchased Shares This Month

8:59 a.m. Nov. 25, 2013
- Seeking Alpha

Gilead And AbbVie Battle For Top Spot In $20 Billion Hepatitis Drug Market

4:37 a.m. Nov. 24, 2013
- Seeking Alpha

Gilead Hepatitis C Drug Wins EU Panel Vote Early

10:28 a.m. Nov. 22, 2013
- Investors Business Daily

Sanofi, Regeneron report good results for arthritis drug

7:07 a.m. Nov. 22, 2013
- Seeking Alpha

Biotech Stock Mailbag: Enanta, Vanda, Pharmacyclics, Top 2014 Stock Catalysts

6:00 a.m. Nov. 22, 2013
- TheStreet.com

New Research And Competition Could Hurt AbbVie's Other Blockbuster

12:21 p.m. Nov. 21, 2013
- Seeking Alpha

Celgene Vs. Rivals In Psoriatic Arthritis Drug Race

4:16 a.m. Nov. 20, 2013
- Seeking Alpha

AbbVie Reports HCV Trial Results - Analyst Blog

7:08 p.m. Nov. 19, 2013
- Zacks.com

European Approval for Gilead's Vitekta - Analyst Blog

11:40 a.m. Nov. 19, 2013
- Zacks.com

Celgene's Revlimid: Sales To $8B? Patent To 2023?

11:02 a.m. Nov. 19, 2013
- Seeking Alpha

6 Value Dividend Stocks You Should Consider For Your Portfolio

9:43 a.m. Nov. 19, 2013
- Seeking Alpha

AbbVie Hepatitis C Treatment Shines In Latest Trials

12:06 p.m. Nov. 18, 2013
- Investors Business Daily

AbbVie Hepatitis C Drug Shows Promise

10:04 a.m. Nov. 18, 2013
- WSJ.com

Product Recalls, New Appointments, Awareness Campaigns, and Stock Price Movements - Research Report on Abbott, AbbVie, Viropharma, Valeant Pharmaceuticals, and Salix Pharmaceuticals
8:00 a.m. Dec. 2, 2013
- PR Newswire

AbbVie Partners with HIV Community to Launch International Awareness Campaign Focused on Women Living with HIV
9:21 a.m. Nov. 26, 2013
- PR Newswire

Grants and Stock Movements of Major Drug Manufacturers - Research Report on AbbVie, Keryx Biopharmaceuticals, Pacira Pharmaceuticals, Rockwell Medical, and Impax Laboratories
8:00 a.m. Nov. 22, 2013
- PR Newswire

Federal Legislation Support, Philanthropic Activities, and Patent Challenges - Research Report on Mylan, Abbott, Actavis, AbbVie, and Agilent Technologies
8:00 a.m. Nov. 19, 2013
- PR Newswire

Today's Research: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc.
6:21 p.m. Nov. 14, 2013
- PR Newswire

AbbVie to Present at Jefferies 2013 Healthcare Conference
8:15 a.m. Nov. 14, 2013
- PR Newswire

Critical Alerts For Johnson and Johnson, AbbVie, Air Products and Chemicals, American Capital, and AFLAC Released By InvestorsObserver
9:31 a.m. Nov. 13, 2013
- PR Newswire

Financial Results, New Drug Applications, and Stock Price Movements - Research Report on Endo, Bristol-Myers Squibb, Express Scripts, AbbVie, and Incyte
8:00 a.m. Nov. 8, 2013
- PR Newswire

AbbVie to Present at Credit Suisse 2013 Healthcare Conference
8:15 a.m. Nov. 7, 2013
- PR Newswire

Clinical Studies, Regulatory Clearance, Financial Results, and Approvals - Research Report on Bristol-Myers Squibb, Merck & Co., Johnson & Johnson, AbbVie, and Novartis
9:00 a.m. Oct. 31, 2013
- PR Newswire

Positive Clinical Trial Results, Patient Enrollment, and Collaborations - Research Report on Pfizer, Medivation, AbbVie, Cigna, and AstraZeneca
9:00 a.m. Oct. 28, 2013
- PR Newswire

Pre-Market Analysis: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc.
10:12 a.m. Oct. 25, 2013
- PR Newswire

AbbVie Reports Third-Quarter 2013 Financial Results
7:54 a.m. Oct. 25, 2013
- PR Newswire

AbbVie Named a Science Top Employer
6:20 p.m. Oct. 24, 2013
- PR Newswire

Financial Results, Quarterly Earnings Schedules, Marketing Authorizations, Completed Acquisitions, and New Drug Applications - Research Report on Johnson & Johnson, AbbVie, GSK, AstraZeneca, and Keryx
8:00 a.m. Oct. 18, 2013
- PR Newswire

OPKO Adds to Growing Technology Portfolio Through Strategic Investment in Biotechnology Company Engaged in the Development of a New Generation of Antibodies
9:00 a.m. Oct. 10, 2013
- BusinessWire

AbbVie to Host Third-Quarter Earnings Conference Call
8:01 a.m. Oct. 4, 2013
- PR Newswire

Under AAAResearchReports.com Microscope: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc.
8:00 a.m. Oct. 4, 2013
- PR Newswire

AbbVie Presents Phase II Data Evaluating the Efficacy of HUMIRA® (adalimumab) in Patients with Hidradenitis Suppurativa (HS), a Chronic Inflammatory Skin Disease
6:00 a.m. Oct. 3, 2013
- PR Newswire

Drug Approvals, Trial Results, and Collaboration- Research Report on Johnson & Johnson, Bristol-Myers Squibb, Eli Lilly, AbbVie, and GSK
8:00 a.m. Sept. 30, 2013
- PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Corra Group Expands Global Hiring with Int'l Screening

Global Workforce, Global Challenges Jumping into the international hiring scene can feel like trying to piece together a puzzle with missing parts. You've got candidates with histories in every corner of the globe, each place following its own playbook. It's not like you can just run your standard checks and call it a day. Corra Group, stepping up to the plate, has now...

Pangaea's Q3 2026: Record TCE Rates and Profits

Unpacking Pangaea's Stellar Q3 Performance Ah, the shipping industry—an ocean of numbers too vast for many, but Pangaea Logistics Solutions Ltd. (NASDAQ: PANL) has shown it knows how to chart a course through complex waters. The company announced mighty fine results for the third quarter of 2026, and folks, if you're looking for a cup of optimism in the logistics...

ASCAP's Bold New Mental Health Move for Creators

Here's something that'll catch your interest if you're in the business of creating music and keeping sane while doing it. ASCAP, the big cheese in the music world, has teamed up with Project Healthy Minds to roll out a heavy-duty mental health benefit for its members. Nothing short of a lifeline for those riding the emotional rollercoaster of the music biz, let me tell...

NORROY's Radiopharma Innovations: EANM Highlights

Breaking Ground: NORROY's Radiopharmaceutical Innovations If you thought the radiopharmaceutical game was stuck in the same ol' rut, NORROY Bioscience just flipped the script. Standing out at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM'26) in Vienna, they trotted out enough breakthroughs to make you wonder if they're secretly running on...

GoldMining Ramps Up São Jorge Environmental Work

GoldMining's Next Big Step in Brazil GoldMining Inc. is rolling up its sleeves in Brazil, diving headfirst into environmental and socioeconomic baseline studies pivotal for the São Jorge Gold Project. Right here, folks, we're seeing the groundwork for what could be a major leap forward. Anyone keeping an eye on TSX:GLDG might be sniffing what's cooking, especially when...

Sharon Bowen Honored; e.l.f. Beauty Hits 31 Quarters

Markets Stir as NYSE Chair Earns Lifetime Award While the financial world often gets lost in numbers, sometimes it's the people who stand out. NYSE Chair Sharon Bowen is taking the spotlight with her lifetime achievement award, underscoring her game-changing influence in governance. This is more than just a pat on the back; it's a nod to the force she’s been in steering...

Hyperliquid Strategies Navigates High Stakes in Fintech

Hyperliquid's Bold Moves in a Volatile Market Hyperliquid Strategies Inc (NASDAQ: PURR) isn't just sitting on the sidelines, folks. They're not dipping their toes, they're cannonballing into the deep end, reporting impressive financial strides as Q3 2026 wraps up. Deploying a whopping $802 million and filing to become a futures commission merchant? That's like setting the...

Risk Map 2027: Navigating Travel Safety Worldwide

Navigating the Complexities of Global Travel Safety Here's the thing folks—a traveler's peace of mind isn't just about sun hats and passports anymore. We're talking pressing global safety dynamics as revealed in the 2027 Risk Map. This ain't your average vacation checklist; it's a deep dive into the evolving tapestry of global security. Whether you’re hopping from the...

Vermiculus Taps New CISO Amid Index Engine Launch

Vermiculus Ups Its Security Game You ever wonder why a company decides to beef up security? Well, Vermiculus ain't leaving anything to chance as they roll out new tech. They've named Alexander Kilian the Chief Information Security Officer. Yep, Kilian's stepping into the ring, and no one’s treating this like a sidebar gig. This market tech outfit isn't just polishing...

GaNrich: Gallium Nitride Game-Changer Expands Global Reach

Rattling the Silicon Cage: GaNrich's Transformative Climb Well, folks, here's a story that makes even the most stoic traders sit up and take notice: GaNrich Semiconductor, a Taiwan-based trailblazer, is serving a wallop to the traditional silicon power device monopoly. By expanding their GaN power device portfolio to cover voltages ranging a whopping 40V to 1200V, GaNrich...